Author:
Durham Stephen R.,Emminger Waltraud,Kapp Alexander,de Monchy Jan G.R.,Rak Sabina,Scadding Glenis K.,Wurtzen Peter A.,Andersen Jens S.,Tholstrup Bente,Riis Bente,Dahl Ronald
Funder
Boehringer Ingelheim
Astma- och Allergiförbundet
Pfizer
GlaxoSmithKline
Novartis
Astellas Pharma US
Teva Pharmaceutical Industries
Subject
Immunology,Immunology and Allergy
Reference36 articles.
1. Prevalence and rate of diagnosis of allergic rhinitis in Europe;Bauchau;Eur Respir J,2004
2. National prevalence of respiratory allergic disorders;Dahl;Respir Med,2004
3. A survey of the burden of allergic rhinitis in the USA;Schatz;Allergy,2007
4. The burden of allergic rhinitis;Nathan;Allergy Asthma Proc,2007
5. EMEA. Guideline on the clinical development on products for specific immunotherapy for the treatment of allergic diseases. EMEA; 2008.Report No. CHMP/EWP/18504/2006. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003605.pdf. Accessed January 17, 2012.
Cited by
453 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献